EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Novel Immunotherapeutics for the Treatment of Non-Small Cell Lung Cancer (NSCLC) Resistant to PD-1/PD-L1 Inhibitors

Jyoti Malhotra iD, Amy Huang, Arya Amini, Percy Lee iD

Cancers · 25.10.2024 · 16 (21) · 3603

DOI: 10.3390/cancers16213603 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 25.10.2024. Verfasst von Jyoti Malhotra und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology & Therapeutics Research, City of Hope National Medical Center, Duarte, CA 91010, USA. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunotherapy with PD-1/PD-L1 inhibitors is the standard method of care for the treatment of newly diagnosed advanced or metastatic NSCLC, with or without chemotherapy. Many tumors, however, develop resistance to these immunotherapy agents. There is a need to develop more effective therapies for patients with metastatic NSCLC in the second-line setting and beyond. In this review, we present an overview of novel immunotherapies being investigated regarding the treatment of these patients. We summarize completed, as well as ongoing, trials investigating these therapies as monotherapy or in combination with PD-1/PD-L1 inhibitors. These include immune co-stimulatory antibodies, T-cell agonists, oncolytic viruses, vaccines, TIL therapies, and CAR-T therapies.

Schlagwörter

Stichwörter der Autor:innen

immunotherapyresistancetrials

Autor:innen und Institutionen

  • Department of Medical Oncology & Therapeutics Research, City of Hope National Medical Center, Duarte, CA 91010, USA.
  • Department of Medicine, University of Connecticut School of Medicine, Farmington, CT 06030, USA.
  • Department of Radiation Oncology, City of Hope National Medical Center, Duarte, CA 91010, USA.

ORCID-Profile: Jyoti Malhotra, Percy Lee

Zitieren

APA

Malhotra, J., Huang, A., Amini, A., & Lee, P. (2024). Novel Immunotherapeutics for the Treatment of Non-Small Cell Lung Cancer (NSCLC) Resistant to PD-1/PD-L1 Inhibitors. Cancers, 16(21), 3603. https://doi.org/10.3390/cancers16213603

Vancouver

Malhotra J, Huang A, Amini A, Lee P. Novel Immunotherapeutics for the Treatment of Non-Small Cell Lung Cancer (NSCLC) Resistant to PD-1/PD-L1 Inhibitors. Cancers. 2024;16(21):3603. doi:10.3390/cancers16213603

BibTeX
@article{Malhotra2024,
  author = {Malhotra, Jyoti and Huang, Amy and Amini, Arya and Lee, Percy},
  title = {Novel Immunotherapeutics for the Treatment of Non-Small Cell Lung Cancer (NSCLC) Resistant to PD-1/PD-L1 Inhibitors},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {21},
  pages = {3603},
  doi = {10.3390/cancers16213603}
}
Kostenlos starten →